145 related articles for article (PubMed ID: 28712302)
1. Overcoming the Hydrolytic Lability of a Reaction Intermediate in Production of Protein/Drug Conjugates: Conjugation of an Acyclic Nucleoside Phosphonate to a Model Carrier Protein.
Xu S; Kaltashov IA
Mol Pharm; 2017 Aug; 14(8):2843-2851. PubMed ID: 28712302
[TBL] [Abstract][Full Text] [Related]
2. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
De Clercq E
Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
[TBL] [Abstract][Full Text] [Related]
3. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
De Clercq E
Clin Microbiol Rev; 2003 Oct; 16(4):569-96. PubMed ID: 14557287
[TBL] [Abstract][Full Text] [Related]
4. Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals.
Krecmerova M
Mini Rev Med Chem; 2017; 17(10):818-833. PubMed ID: 28215138
[TBL] [Abstract][Full Text] [Related]
5. Chiral analysis of anti-acquired immunodeficiency syndrome drug, 9-(R)-[2-(phosphonomethoxy)propyl]adenine (tenofovir), and related antiviral acyclic nucleoside phosphonates by CE using beta-CD as chiral selector.
Solínová V; Kasicka V; Sázelová P; Holý A
Electrophoresis; 2009 Jun; 30(12):2245-54. PubMed ID: 19544492
[TBL] [Abstract][Full Text] [Related]
6. The Holý Trinity: the acyclic nucleoside phosphonates.
De Clercq E
Adv Pharmacol; 2013; 67():293-316. PubMed ID: 23886004
[TBL] [Abstract][Full Text] [Related]
7. Characterization of intact protein conjugates and biopharmaceuticals using ion-exchange chromatography with online detection by native electrospray ionization mass spectrometry and top-down tandem mass spectrometry.
Muneeruddin K; Nazzaro M; Kaltashov IA
Anal Chem; 2015 Oct; 87(19):10138-45. PubMed ID: 26360183
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of pradefovir, PMEA and tenofovir in HBV patient serum using liquid chromatography-tandem mass spectrometry and application to phase 2 clinical trial.
Xiao Q; Wang D; Yang W; Chen L; Ding Y; Yang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():133-140. PubMed ID: 27089519
[TBL] [Abstract][Full Text] [Related]
9. The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond.
De Clercq E
Biochem Pharmacol; 2011 Jul; 82(2):99-109. PubMed ID: 21501598
[TBL] [Abstract][Full Text] [Related]
10. Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.
Bi HC; Zhong GP; Zhou S; Chen X; Huang M
Rapid Commun Mass Spectrom; 2005; 19(20):2911-7. PubMed ID: 16167376
[TBL] [Abstract][Full Text] [Related]
11. The discovery of antiviral agents: ten different compounds, ten different stories.
De Clercq E
Med Res Rev; 2008 Nov; 28(6):929-53. PubMed ID: 18438800
[TBL] [Abstract][Full Text] [Related]
12. Gln151 of HIV-1 reverse transcriptase acts as a steric gate towards clinically relevant acyclic phosphonate nucleotide analogues.
Frangeul A; Bussetta C; Deval J; Barral K; Alvarez K; Canard B
Antivir Ther; 2008; 13(1):115-24. PubMed ID: 18389906
[TBL] [Abstract][Full Text] [Related]
13. [Determination of adefovir in monkey plasma by liquid chromatography-tandem mass spectrometry].
Zhao LY; Chen XY; Zhang Y; Yang HY; Zhong DF
Yao Xue Xue Bao; 2003 Feb; 38(2):120-3. PubMed ID: 12778747
[TBL] [Abstract][Full Text] [Related]
14. A fragmentation-based method for the differentiation of glutathione conjugates by high-resolution mass spectrometry with electrospray ionization.
Xie C; Zhong D; Chen X
Anal Chim Acta; 2013 Jul; 788():89-98. PubMed ID: 23845486
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
Cundy KC
Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
[TBL] [Abstract][Full Text] [Related]
16. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study.
Xiong Z; Zhang Y; Qin F; Qin T; Yang S; Li F
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2111-6. PubMed ID: 20630813
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.
Ruiz JC; Beadle JR; Aldern KA; Keith KA; Hartline CB; Kern ER; Hostetler KY
Antiviral Res; 2007 Jul; 75(1):87-90. PubMed ID: 17367874
[TBL] [Abstract][Full Text] [Related]
18. Permeation enhancer dodecyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: influence of pH, ion-pairing and skin species.
Vávrová K; Lorencová K; Novotný J; Holý A; Hrabálek A
Eur J Pharm Biopharm; 2008 Nov; 70(3):901-7. PubMed ID: 18675907
[TBL] [Abstract][Full Text] [Related]
19. Bisamidate Prodrugs of 2-Substituted 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis.
Česnek M; Jansa P; Šmídková M; Mertlíková-Kaiserová H; Dračínský M; Brust TF; Pávek P; Trejtnar F; Watts VJ; Janeba Z
ChemMedChem; 2015 Aug; 10(8):1351-64. PubMed ID: 26136378
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantitation of the nucleotide analog adefovir, its phosphorylated anabolites and 2'-deoxyadenosine triphosphate by ion-pairing LC/MS/MS.
Vela JE; Olson LY; Huang A; Fridland A; Ray AS
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):335-43. PubMed ID: 17101307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
